BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 6, 2026
Home » Authors » Larry Haimovitch

Larry Haimovitch

Articles

ARTICLES

Prostate cancer therapies in the spotlight at AUA meeting

April 30, 2009
By Larry Haimovitch
CHICAGO — The annual meeting of the American Urological Association (AUA; Linthicum, Maryland) the largest worldwide meeting for this specialty, is taking place here. Although a broad variety of topics are traditionally covered at this meeting, prostate cancer remains a crucial focus at every AUA meeting. And well it should, as it is the most common cancer in men with about one in six American men predicted to get prostate cancer during his lifetime. (Diagnostics & Imaging Week)
Read More

Prostate cancer therapies in the spotlight at AUA meeting

April 29, 2009
By Larry Haimovitch
CHICAGO — The annual meeting of the American Urological Association (AUA; Linthicum, Maryland) the largest worldwide meeting for this specialty, is taking place here. Although a broad variety of topics are traditionally covered at this meeting, prostate cancer remains a crucial focus at every AUA meeting. And well it should, as it is the most common cancer in men with about one in six American men predicted to get prostate cancer during his lifetime. (Medical Device Daily)
Read More

Study shows costs improve for DES vs. surgery for some patients

April 1, 2009
By Larry Haimovitch
ORLANDO — With a massive number of clinical trial data being reported here the past few days, winnowing out the most important ones became a major challenge. However, one trial that stood out from the crowd because of its focus on quality of life (QOL) and healthcare cost outcomes was the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial. (Medical Device Daily)
Read More

Watchman shown to be better than warfarin for non-valvular AF

March 31, 2009
By Larry Haimovitch
ORLANDO — The 58th annual scientific session of the American College of Cardiology (ACC; Bethesda, Maryland) kicked off here early on Saturday morning with a session devoted to "Late Breaking Clinical Trials." (Medical Device Daily)
Read More

AFib seen as a hot sector for new technology developments

March 11, 2009
By Larry Haimovitch

Macular degeneration remains a key topic for retinal specialists

March 1, 2009
By Larry Haimovitch

Despite missing its endpoint, NEST-2 trial shows promise

Feb. 24, 2009
By Larry Haimovitch

Macular degeneration a key topic for retinal specialists

Jan. 28, 2009
By Larry Haimovitch
WAILEA MAUI, Hawaii – The annual Hawaiian Eye Meeting was held here last week at the Grand Wailea Resort as specialists from three key ophthalmic specialties – cataract, refractive and retinal surgery – gathered to hear the latest clinical information and to enjoy the sunny and warm weather. (Medical Device Daily)
Read More

Big proposed deal sharpens focus on ophthalmology space

Jan. 21, 2009
By Larry Haimovitch

Economy roils sector, but big players cite some positive signs

Jan. 1, 2009
By Larry Haimovitch
View All Articles by Larry Haimovitch

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Illustration of liver being targets with cross-hairs

    Study identifies CAND1 as therapeutic target in hepatoblastoma

    BioWorld Science
    Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing